 | • レポートコード：MRC2102QY11599 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の原発性高シュウ酸尿症薬市場について種類別（ALLN-230、DCR-PHXC、ALN-GO1、その他）、用途別（病院、診療所、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・原発性高シュウ酸尿症薬市場の概要 ・世界の主要地域別原発性高シュウ酸尿症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の原発性高シュウ酸尿症薬市場規模2015-2026：種類別（ALLN-230、DCR-PHXC、ALN-GO1、その他） ・世界の原発性高シュウ酸尿症薬市場規模2015-2026：用途別（病院、診療所、その他） ・原発性高シュウ酸尿症薬の米国市場規模2015-2020 ・原発性高シュウ酸尿症薬のヨーロッパ市場規模2015-2020 ・原発性高シュウ酸尿症薬の中国市場規模2015-2020 ・原発性高シュウ酸尿症薬の日本市場規模2015-2020 ・原発性高シュウ酸尿症薬の東南アジア市場規模2015-2020 ・原発性高シュウ酸尿症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・原発性高シュウ酸尿症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・原発性高シュウ酸尿症薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Primary Hyperoxaluria Drug Market
The global Primary Hyperoxaluria Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Primary Hyperoxaluria Drug Scope and Market Size
The global Primary Hyperoxaluria Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Primary Hyperoxaluria Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Primary Hyperoxaluria Drug market is segmented into
ALLN-230
DCR-PHXC
ALN-GO1
Others
Segment by Application, the Primary Hyperoxaluria Drug market is segmented into
Hospital
Clinic
Others
The Primary Hyperoxaluria Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Primary Hyperoxaluria Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Primary Hyperoxaluria Drug Market Share Analysis
Primary Hyperoxaluria Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primary Hyperoxaluria Drug business, the date to enter into the Primary Hyperoxaluria Drug market, Primary Hyperoxaluria Drug product introduction, recent developments, etc.
The major vendors covered:
Allena Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Intellia Therapeutics Inc
OxThera AB
1 Primary Hyperoxaluria Drug Market Overview
1.1 Primary Hyperoxaluria Drug Product Scope
1.2 Primary Hyperoxaluria Drug Segment by Type
1.2.1 Global Primary Hyperoxaluria Drug Sales by Type (2020-2026)
1.2.2 ALLN-230
1.2.3 DCR-PHXC
1.2.4 ALN-GO1
1.2.5 Others
1.3 Primary Hyperoxaluria Drug Segment by Application
1.3.1 Global Primary Hyperoxaluria Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Primary Hyperoxaluria Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Primary Hyperoxaluria Drug Sales Growth Rate (2015-2026)
1.4.2 Global Primary Hyperoxaluria Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Primary Hyperoxaluria Drug Price Trends (2015-2026)
2 Primary Hyperoxaluria Drug Estimate and Forecast by Region
2.1 Global Primary Hyperoxaluria Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Primary Hyperoxaluria Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2020)
2.3 Global Primary Hyperoxaluria Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Primary Hyperoxaluria Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
2.4.2 Europe Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
2.4.3 China Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
2.4.4 Japan Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
2.4.6 India Primary Hyperoxaluria Drug Estimates and Projections (2015-2026)
3 Global Primary Hyperoxaluria Drug Competition Landscape by Players
3.1 Global Top Primary Hyperoxaluria Drug Players by Sales (2015-2020)
3.2 Global Top Primary Hyperoxaluria Drug Players by Revenue (2015-2020)
3.3 Global Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Hyperoxaluria Drug as of 2019)
3.4 Global Primary Hyperoxaluria Drug Average Price by Company (2015-2020)
3.5 Manufacturers Primary Hyperoxaluria Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Primary Hyperoxaluria Drug Players (Opinion Leaders)
4 Global Primary Hyperoxaluria Drug Market Size by Type
4.1 Global Primary Hyperoxaluria Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Primary Hyperoxaluria Drug Price by Type (2015-2020)
4.2 Global Primary Hyperoxaluria Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Primary Hyperoxaluria Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Primary Hyperoxaluria Drug Price Forecast by Type (2021-2026)
5 Global Primary Hyperoxaluria Drug Market Size by Application
5.1 Global Primary Hyperoxaluria Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Primary Hyperoxaluria Drug Price by Application (2015-2020)
5.2 Global Primary Hyperoxaluria Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Primary Hyperoxaluria Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Primary Hyperoxaluria Drug Price Forecast by Application (2021-2026)
6 United States Primary Hyperoxaluria Drug Market Facts & Figures
6.1 United States Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
6.2 United States Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
6.3 United States Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
7 Europe Primary Hyperoxaluria Drug Market Facts & Figures
7.1 Europe Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
7.2 Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
7.3 Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
8 China Primary Hyperoxaluria Drug Market Facts & Figures
8.1 China Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
8.2 China Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
8.3 China Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
9 Japan Primary Hyperoxaluria Drug Market Facts & Figures
9.1 Japan Primary Hyperoxaluria Drug Sales Market Share by Company (3015-3030)
9.2 Japan Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
9.3 Japan Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Primary Hyperoxaluria Drug Market Facts & Figures
10.1 Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
11 India Primary Hyperoxaluria Drug Market Facts & Figures
11.1 India Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
11.2 India Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
11.3 India Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Primary Hyperoxaluria Drug Business
12.1 Allena Pharmaceuticals Inc
12.1.1 Allena Pharmaceuticals Inc Corporation Information
12.1.2 Allena Pharmaceuticals Inc Business Overview
12.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
12.1.5 Allena Pharmaceuticals Inc Recent Development
12.2 Alnylam Pharmaceuticals Inc
12.2.1 Alnylam Pharmaceuticals Inc Corporation Information
12.2.2 Alnylam Pharmaceuticals Inc Business Overview
12.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
12.2.5 Alnylam Pharmaceuticals Inc Recent Development
12.3 Dicerna Pharmaceuticals Inc
12.3.1 Dicerna Pharmaceuticals Inc Corporation Information
12.3.2 Dicerna Pharmaceuticals Inc Business Overview
12.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
12.3.5 Dicerna Pharmaceuticals Inc Recent Development
12.4 Intellia Therapeutics Inc
12.4.1 Intellia Therapeutics Inc Corporation Information
12.4.2 Intellia Therapeutics Inc Business Overview
12.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Products Offered
12.4.5 Intellia Therapeutics Inc Recent Development
12.5 OxThera AB
12.5.1 OxThera AB Corporation Information
12.5.2 OxThera AB Business Overview
12.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 OxThera AB Primary Hyperoxaluria Drug Products Offered
12.5.5 OxThera AB Recent Development
…
13 Primary Hyperoxaluria Drug Manufacturing Cost Analysis
13.1 Primary Hyperoxaluria Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Primary Hyperoxaluria Drug
13.4 Primary Hyperoxaluria Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Primary Hyperoxaluria Drug Distributors List
14.3 Primary Hyperoxaluria Drug Customers
15 Market Dynamics
15.1 Primary Hyperoxaluria Drug Market Trends
15.2 Primary Hyperoxaluria Drug Opportunities and Drivers
15.3 Primary Hyperoxaluria Drug Market Challenges
15.4 Primary Hyperoxaluria Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Primary Hyperoxaluria Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Primary Hyperoxaluria Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Primary Hyperoxaluria Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2020)
Table 6. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Primary Hyperoxaluria Drug Revenue Share by Region (2015-2020)
Table 8. Global Primary Hyperoxaluria Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Primary Hyperoxaluria Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Primary Hyperoxaluria Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Primary Hyperoxaluria Drug Sales Share by Company (2015-2020)
Table 14. Global Primary Hyperoxaluria Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Primary Hyperoxaluria Drug Revenue Share by Company (2015-2020)
Table 16. Global Primary Hyperoxaluria Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Hyperoxaluria Drug as of 2019)
Table 17. Global Primary Hyperoxaluria Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Primary Hyperoxaluria Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Primary Hyperoxaluria Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Primary Hyperoxaluria Drug Players
Table 22. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Primary Hyperoxaluria Drug Sales Share by Type (2015-2020)
Table 24. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Primary Hyperoxaluria Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Primary Hyperoxaluria Drug Sales Share by Type (2021-2026)
Table 27. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Primary Hyperoxaluria Drug Revenue Share by Type (2021-2026)
Table 29. Global Primary Hyperoxaluria Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Primary Hyperoxaluria Drug Sales Share by Application (2015-2020)
Table 32. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Primary Hyperoxaluria Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Primary Hyperoxaluria Drug Sales Share by Application (2021-2026)
Table 36. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Primary Hyperoxaluria Drug Revenue Share by Application (2021-2026)
Table 38. Global Primary Hyperoxaluria Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 41. United States Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 43. United States Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 51. China Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 53. China Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 55. China Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 69. India Primary Hyperoxaluria Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Primary Hyperoxaluria Drug Sales Market Share by Company (2015-2020)
Table 71. India Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 73. India Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 75. Allena Pharmaceuticals Inc Corporation Information
Table 76. Allena Pharmaceuticals Inc Description and Business Overview
Table 77. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 79. Allena Pharmaceuticals Inc Recent Development
Table 80. Alnylam Pharmaceuticals Inc Corporation Information
Table 81. Alnylam Pharmaceuticals Inc Description and Business Overview
Table 82. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 84. Alnylam Pharmaceuticals Inc Recent Development
Table 85. Dicerna Pharmaceuticals Inc Corporation Information
Table 86. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 87. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product
Table 89. Dicerna Pharmaceuticals Inc Recent Development
Table 90. Intellia Therapeutics Inc Corporation Information
Table 91. Intellia Therapeutics Inc Description and Business Overview
Table 92. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product
Table 94. Intellia Therapeutics Inc Recent Development
Table 95. OxThera AB Corporation Information
Table 96. OxThera AB Description and Business Overview
Table 97. OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. OxThera AB Primary Hyperoxaluria Drug Product
Table 99. OxThera AB Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Primary Hyperoxaluria Drug Distributors List
Table 103. Primary Hyperoxaluria Drug Customers List
Table 104. Primary Hyperoxaluria Drug Market Key Trends
Table 105. Primary Hyperoxaluria Drug Key Opportunities and Drivers
Table 106. Primary Hyperoxaluria Drug Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Hyperoxaluria Drug Product Picture
Figure 2. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Primary Hyperoxaluria Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Primary Hyperoxaluria Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Primary Hyperoxaluria Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Primary Hyperoxaluria Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Primary Hyperoxaluria Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Primary Hyperoxaluria Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Primary Hyperoxaluria Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Primary Hyperoxaluria Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Primary Hyperoxaluria Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Primary Hyperoxaluria Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Primary Hyperoxaluria Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Primary Hyperoxaluria Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Primary Hyperoxaluria Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Primary Hyperoxaluria Drug Players Market Share by Revenue in Primary Hyperoxaluria Drug 2015 & 2019
Figure 27. Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Primary Hyperoxaluria Drug Revenue Share by Type (2015-2020)
Figure 29. Global Primary Hyperoxaluria Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Primary Hyperoxaluria Drug Revenue Share by Application (2015-2020)
Figure 31. Global Primary Hyperoxaluria Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 33. United States Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 34. Europe Primary Hyperoxaluria Drug Sales Market Share by Company in 2019
Figure 35. Europe Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 36. Europe Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 37. China Primary Hyperoxaluria Drug Sales Market Share by Company in 2019
Figure 38. China Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 39. China Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 40. Japan Primary Hyperoxaluria Drug Sales Market Share by Company in 2019
Figure 41. Japan Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 42. Japan Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 46. India Primary Hyperoxaluria Drug Sales Market Share by Company in 2019
Figure 47. India Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 48. India Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Primary Hyperoxaluria Drug
Figure 51. Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure 52. Primary Hyperoxaluria Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …
- 耳鳴症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Tinnitus Drug Market The global Tinnitus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tinnitus Drug Scope and Market Size The global Tinnitus Drug market is segmented by comp…
- ドラッグキャビネットの世界市場レポート2020 Market Analysis and Insights: Global Drug Cabinets Market The global Drug Cabinets market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Drug Cabinets Scope and Market Size The global Drug Cabinets market is segmented by comp…